Cardiovascular risk stratification and appropriate use of statins in patients with systemic lupus erythematosus according to different strategies

ConclusionsOur findings showed that a large proportion of patients with SLE have a considerable cardiovascular risk and many of them would be eligible for statin therapy. However, the statin use observed was low.Key Points• A large proportion of patients with lupus have a considerable cardiovascular risk, explained in part by dyslipidemia.• Many patients with SLE would be eligible for statin therapy according to risk stratification based on conventional risk factors.• The use of statins in this population is inadequate.
Source: Clinical Rheumatology - Category: Rheumatology Source Type: research